Arginine 16 glycine polymorphism in β 2-adrenergic receptor gene is associated with obesity, hyperlipidemia, hyperleptinemia, and insulin resistance in saudis

International Journal of Endocrinology

Volumn 2012, Issue , 2012, Pages

  Daghestani, Maha H ^a,b   Warsy, Arjumand ^a   Daghestani, Mazin H ^c   Al Odaib, Ali N ^b   Eldali, Abdelmoneim ^b   Al Eisa, Nadia A ^a   Omer, Sawsan A ^a   Hassan, Zeinab K ^a  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

^b KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

^c UMM AL QURA UNIVERSITY   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; BETA 2 ADRENERGIC RECEPTOR; CHOLESTEROL; GENOMIC DNA; GLUCOSE; GLYCINE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LEPTIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ANTHROPOMETRIC PARAMETERS; ARTICLE; BETA 2 ADRENERGIC RECEPTOR GENE; BODY MASS; CONTROLLED STUDY; DNA SEQUENCE; FEMALE; GENE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HIP CIRCUMFERENCE; HUMAN; HYPERLEPTINEMIA; HYPERLIPIDEMIA; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; METABOLIC PARAMETERS; OBESITY; PRIORITY JOURNAL; SAUDI ARABIA; WAIST CIRCUMFERENCE; WAIST HIP RATIO;

EID: 84867828285     PISSN: 16878337     EISSN: 16878345     Source Type: Journal    
DOI: 10.1155/2012/945608     Document Type: Article

References (39)

1. Bouchard C., Current understanding of the etiology of obesity: genetic and nongenetic factors. American Journal of Clinical Nutrition 1991 53 6 1561 1565 2-s2.0-0025740249
2. Spiegelman B. M., Flier J. S., Adipogenesis and obesity: rounding out the big picture. Cell 1996 87 3 377 389 2-s2.0-0030297919 10.1016/S0092-8674(00) 81359-8 (Pubitemid 26374313)
3. Rankinen T., Zuberi A., Chagnon Y. C., Weisnagel S. J., Argyropoulos G., Walts B., Pérusse L., Bouchard C., The human obesity gene map: the 2005 update. Obesity 2006 14 4 529 644 2-s2.0-33749017409 10.1038/oby.2006.71 (Pubitemid 46219737)
4. Lafontan M., Berlan M., Fat cell adrenergic receptors and the control of white and brown fat cell function. Journal of Lipid Research 1993 34 7 1057 1091 2-s2.0-0027287413 (Pubitemid 23199155)
5. Lonnqvist F., Wahrenberg H., Hellstrom L., Reynisdottir S., Arner P., Lipolytic catecholamine resistance due to decreased β 2-adrenoceptor expression in fat cells. Journal of Clinical Investigation 1992 90 6 2175 2186 2-s2.0-0027102383 (Pubitemid 23010031)
6. 3-adrenoceptor in man. Journal of Clinical Investigation 1995 95 5 2239 2245 2-s2.0-0028968883
7. Barbe P., Millet L., Galitzky J., Lafontan M., Berlan M., In situ assessment of the role of the β 1-, β 2- and β 3-adrenoceptors in the control of lipolysis and nutritive blood flow in human subcutaneous adipose tissue. British Journal of Pharmacology 1996 117 5 907 913 2-s2.0-0029670099
8. Green S. A., Turki J., Hall I. P., Liggett S. B., Implications of genetic variability of human β 2-adrenergic receptor structure. Pulmonary Pharmacology 1995 8 1 1 10 2-s2.0-0028791628 10.1006/pulp.1995.1001
9. Liggett S. B., Pharmacogenetics of beta-1- and beta-2-adrenergic receptors. Pharmacology 2000 61 3 167 173 2-s2.0-0033832449
10. Green S. A., Turki J., Innis M., Liggett S. B., Amino-terminal polymorphisms of the human beta 2-adrenergic receptor impart distinct agonist-promoted regulatory properties. Biochemistry 1994 33 32 9414 9419 2-s2.0-0028029628 (Pubitemid 24272896)
11. Green S. A., Cole G., Jacinto M., Innis M., Liggett S. B., A polymorphism of the human β 2-adrenergic receptor within the fourth transmembrane domain alters ligand binding and functional properties of the receptor. Journal of Biological Chemistry 1993 268 31 23116 23121 2-s2.0-0027519404 (Pubitemid 23328021)
12. Ishiyama-Shigemoto S., Yamada K., Yuan X., Ichikawa F., Nonaka K., Association of polymorphisms in the β 2-adrenergic receptor gene with obesity, hypertriglyceridaemia, and diabetes mellitus. Diabetologia 1999 42 1 98 101 2-s2.0-0032587498 10.1007/s001250051120 (Pubitemid 29039745)
13. Iwamoto N., Ogawa Y., Kajihara S., Hisatomi A., Yasutake T., Yoshimura T., Mizuta T., Hara T., Ozaki I., Yamamoto K., Gln27Glu β 2-adrenergic receptor variant is associated with hypertriglyceridemia and the development of fatty liver. Clinica Chimica Acta 2001 314 1-2 85 91 2-s2.0-0035170038 10.1016/S0009-8981(01)00633-7 (Pubitemid 33079186)
14. Arner P., Genetic variance and lipolysis regulation: implications for obesity. Annals of Medicine 2001 33 8 542 546 2-s2.0-0035173140 (Pubitemid 33052275)
15. Ukkola O., Rankinen T., Weisnagel S. J., Sun G., Perusse L., Chagnon Y. C., Despres J. P., Bouchard C., Interactions among the α 2-, β 2-, and β 3-adrenergic receptor genes and obesity-related phenotypes in the Quebec Family Study. Metabolism 2000 49 8 1063 1070 2-s2.0-0034243110 10.1053/meta.2000.7708 (Pubitemid 30641446)
16. Mori Y., Kim-Motoyama H., Ito Y., Katakura T., Yasuda K., Ishiyama-Shigemoto S., Yamada K., Akanuma Y., Ohashi Y., Kimura S., Yazaki Y., Kadowaki T., The Gln27Glu β 2-adrenergic receptor variant is associated with obesity due to subcutaneous fat accumulation in Japanese men. Biochemical and Biophysical Research Communications 1999 258 1 138 140 2-s2.0-0033614302 10.1006/bbrc.1999.0607 (Pubitemid 29287016)
17. Masuo K., Katsuya T., Fu Y., Rakugi H., Ogihara T., Tuck M. L., β 2-adrenoceptor polymorphisms relate to insulin resistance and sympathetic overactivity as early markers of metabolic disease in nonobese, normotensive individuals. American Journal of Hypertension 2005 18 7 1009 1014 2-s2.0-22844435290 10.1016/j.amjhyper.2005.01.006 (Pubitemid 41040275)
18. 2-Adrenoceptor polymorphisms relate to obesity through blunted leptin mediated sympathetic activation. American Journal of Hypertension 2006 19 10 1084 1091 2-s2.0-33749353201 10.1016/j.amjhyper.2006.02.015 (Pubitemid 44488664)
19. Large V., Hellström L., Reynisdottir S., Lönnqvist F., Eriksson P., Lannfelt L., Arner P., Human beta-2 adrenoceptor gene polymorphisms are highly frequent in obesity and associate with altered adipocyte beta-2 adrenoceptor function. Journal of Clinical Investigation 1997 100 12 3005 3013 2-s2.0-0031436966 (Pubitemid 28022837)
20. Leineweber K., Büscher R., Bruck H., Brodde O. E., β -Adrenoceptor polymorphisms. Naunyn-Schmiedeberg's Archives of Pharmacology 2004 369 1 1 22 2-s2.0-0742269427 10.1007/s00210-003-0824-2 (Pubitemid 38161220)
21. Masuo K., Katsuya T., Fu Y., Rakugi H., Ogihara T., Tuck M. L., β 2- and β 3-adrenergic receptor polymorphisms are related to the onset of weight gain and blood pressure elevation over 5 years. Circulation 2005 111 25 3429 3434 2-s2.0-21544454653 10.1161/CIRCULATIONAHA.104.519652 (Pubitemid 40923396)
22. Kawaguchi H., Masuo K., Katsuya T., Sugimoto K., Rakugi H., Ogihara T., Tuck M. L., β 2- and β 3-adrenoceptor polymorphisms relate to subsequent weight gain and blood pressure elevation in obese normotensive individuals. Hypertension Research 2006 29 12 951 959 2-s2.0-33846827079 10.1291/hypres.29.951 (Pubitemid 46206581)
23. Kim S. H., Kim D. J., Seo I. A., Min Y. K., Lee M. S., Kim K. W., Lee M. K., Significance of β 2-adrenergic receptor gene polymorphism in obesity and type 2 diabetes mellitus in Korean subjects. Metabolism 2002 51 7 833 837 2-s2.0-0036634633 10.1053/meta.2002.33347 (Pubitemid 34784806)
24. Gjesing A. P., Andersen G., Burgdorf K. S., Borch-Johnsen K., Jorgensen T., Hansen T., Pedersen O., Studies of the associations between functional β 2- adrenergic receptor variants and obesity, hypertension and type 2 diabetes in 7,808 white subjects. Diabetologia 2007 50 3 563 568 2-s2.0-33846786457 10.1007/s00125-006-0578-8 (Pubitemid 46215499)
25. Garenc C., Pérusse L., Chagnon Y. C., Rankinen T., Gagnon J., Borecki I. B., Leon A. S., Skinner J. S., Wilmore J. H., Rao D. C., Bouchard C., Effects of β 2-adrenergic receptor gene variants on adiposity: the HERITAGE Family Study. Obesity Research 2003 11 5 612 618 2-s2.0-3343023655 (Pubitemid 41151611)
26. Hayakawa T., Nagai Y., Kahara T., Yamashita H., Takamura T., Abe T., Nomura G., Kobayashi K. I., Gln27Glu and Arg16Gly polymorphisms of the β 2-adrenergic receptor gene are not associated with obesity in Japanese men. Metabolism 2000 49 9 1215 1218 2-s2.0-0033812163 10.1053/meta.2000.8622
27. Mattevi V. S., Zembrzuski V. M., Hutz M. H., Impact of variation in ADRB2, ADRB3, and GNB3 genes on body mass index and waist circumference in a Brazilian population. American Journal of Human Biology 2006 18 2 182 186 2-s2.0-33645575933 10.1002/ajhb.20486
28. Daghestani M. H., Warsy A. A., Daghestani M. H., Al-Odaib A. N., Eldali A., Al-Eisa N. A., Al-Zhrani S., The Gln27Glu polymorphism in β 2-adrenergic receptor gene is linked to hypertriglyceridemia, hyperinsulinemia and hyperleptinemia in Saudis. Lipids in Health and Disease 2010 9, article 90 2-s2.0-77955787247 10.1186/1476-511X-9-90
29. Al-Nozha M. M., Al-Mazrou Y. Y., Al-Maatouq M. A., Arafah M. R., Khalil M. Z., Khan N. B., Al-Marzouki K., Abdullah M. A., Al-Khadra A. H., Al-Harthi S. S., Al-Shahid M. S., Al-Mobeireek A., Nouh M. S., Obesity in Saudi Arabia. Saudi Medical Journal 2005 26 5 824 829 2-s2.0-21344432820 (Pubitemid 40903350)
30. Al-Malki J. S., Al-Jaser M. H., Warsy A. S., Overweight and obesity in Saudi females of childbearing age. International Journal of Obesity 2003 27 1 134 139 2-s2.0-0037255272 10.1038/sj.ijo.0802181 (Pubitemid 36152791)
31. Warsy A. S., El-Hazmi M. A. F., Diabetes mellitus, hypertension and obesitycommon multifactorial disorders in Saudis. Eastern Mediterranean Health Journal 1999 5 6 1236 1242 2-s2.0-0033232286
32. Daghestani M. H., Levels of leptin and reproductive hormones and detection of leptin receptor gene in Saudi Females with Polycystic ovary syndrome [Ph.D. thesis] 2006 King Saud University, Zoology Department
33. Galletti F., Iacone R., Ragone E., Russo O., Della Valle E., Siani A., Barba G., Farinaro E., Strazzullo V., Strazzullo P., Lack of association between polymorphism in the β 2- adrenergic receptor gene, hypertension, and obesity in the Olivetti Heart Study. American Journal of Hypertension 2004 17 8 718 720 2-s2.0-4143151971 10.1016/j.amjhyper.2004.04.012 (Pubitemid 39091554)
34. Kershaw E. E., Flier J. S., Adipose tissue as an endocrine organ. Journal of Clinical Endocrinology and Metabolism 2004 89 6 2548 2556 2-s2.0-2942650969 10.1210/jc.2004-0395 (Pubitemid 38766330)
35. Havel P. J., Role of adipose tissue in body-weight regulation: mechanisms regulating leptin production and energy balance. Proceedings of the Nutrition Society 2000 59 3 359 371 2-s2.0-0033811444
36. Mantzoros C. S., Moschos S. J., Leptin: In search of role(s) in human physiology and pathophysiology. Clinical Endocrinology 1998 49 5 551 567 2-s2.0-0031767057 10.1046/j.1365-2265.1998.00571.x (Pubitemid 28529751)
37. Matthews D. R., Hosker J. P., Rudenski A. S., Homeostasis model assessment: insulin resistance and β -cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985 28 7 412 419 2-s2.0-0021813187 (Pubitemid 15018832)
38. Reynisdottir S., Wahrenberg H., Carlstrom K., Rossner S., Arner P., Catecholamine resistance in fat cells of women with upper-body obesity due to decreased expression of beta2-adrenoceptors. Diabetologia 1994 37 4 428 435 2-s2.0-0028347238 (Pubitemid 24113577)
39. Jocken J. W. E., Blaak E. E., Catecholamine-induced lipolysis in adipose tissue and skeletal muscle in obesity. Physiology and Behavior 2008 94 2 219 230 2-s2.0-42949140834 10.1016/j.physbeh.2008.01.002 (Pubitemid 351615431)